Opportunities for Conducting Vaccine Trials

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0

Sites Throughout LATAM

+ 200

Patients in our network

+ 0

Conducted Studies

0 %

Lost-to-Follow Up rate

As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Opportunities for Conducting Vaccine Trials

Opportunities for Conducting Vaccine Trials in Brazil – CRO Full Service.

Brazil is the largest country in South America, with a population of over 200 million people. The country is known for its rich culture, diverse landscape, and vibrant economy. However, Brazil is also facing significant public health challenges, including high rates of infectious diseases, chronic illnesses, and poor health outcomes.

One way to address these challenges is through the development and testing of vaccines. In this blog post, we will explore the opportunities for conducting vaccine trials in Brazil.

Strong Healthcare Infrastructure

Brazil has a strong healthcare infrastructure that is well-equipped to conduct clinical trials.

The country has a centralized healthcare system, with the Unified Health System (SUS) providing free healthcare to over 75% of the population. The SUS has a well-established network of public hospitals, clinics, and health centers that can provide support for vaccine trials.

Additionally, Brazil has a regulatory framework for clinical research that is modeled after international standards, and the country’s National Health Surveillance Agency (ANVISA) is responsible for regulating clinical trials and ensuring compliance with ethical and scientific standards.

Diverse Population

Another advantage of conducting vaccine trials in Brazil is the country’s diverse population. Brazil has a rich cultural heritage and a diverse population that includes Indigenous peoples, Afro-Brazilians, and people of European descent.

This diversity offers a unique opportunity to test vaccines in different populations with different genetic backgrounds, lifestyles, and healthcare experiences.

Additionally, Brazil’s large population and geographic diversity can help researchers better understand how vaccines work in different regions of the country and can help ensure that vaccines are effective for everyone, regardless of their background or location.

Experience with Infectious Diseases

Brazil has a long history of dealing with infectious diseases, including Zika, dengue fever, yellow fever, and COVID-19. These experiences have helped to build a strong public health infrastructure and a skilled workforce of healthcare professionals.

Additionally, Brazil’s experience with infectious diseases can help researchers better understand the epidemiology of infectious diseases and can help identify potential risks and challenges associated with vaccine development and testing.

Opportunities for Conducting Vaccine Trials

Opportunities for Conducting Vaccine Trials

Investment in Science and Technology

Brazil has made significant investments in science and technology in recent years. The country has established a national science and technology policy that includes funding for research and development.

Additionally, Brazil has established partnerships with international organizations and academic institutions to support research in a variety of fields, including healthcare.

These investments in science and technology can help to support vaccine research and development in Brazil and can help ensure that the country remains at the forefront of medical innovation.

Infrastructure for Manufacturing Vaccines

Brazil has a strong infrastructure for the manufacturing of vaccines. The country has several world-class biotechnology companies and research institutions that can provide support for vaccine manufacturing.

Additionally, Brazil has a strong tradition of vaccine production, and the country is one of the world’s largest producers of vaccines for yellow fever, meningitis, and other diseases.

This infrastructure for vaccine manufacturing can help to accelerate the development and production of vaccines and can help to ensure that vaccines are available to those who need them.

Conclusion

In conclusion, Brazil offers many opportunities for conducting vaccine trials. The country has a strong healthcare infrastructure, a diverse population, experience with infectious diseases, a commitment to science and technology, and infrastructure for vaccine manufacturing.

These factors make Brazil an attractive location for vaccine trials, and they offer a unique opportunity to test vaccines in a variety of populations with different backgrounds and experiences. As vaccine research continues to evolve and new vaccines are developed, Brazil is poised to play a leading role in this important area of medical research.

hat is conducted there.

Opportunities for Conducting Vaccine Trials

Source: Johnson & Johnson

Welcome to Cohortias!

The CRO
of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Opportunities for Conducting Vaccine Trials

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.

Opportunities for Conducting Vaccine Trials

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Opportunities for Conducting Vaccine Trials

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Opportunities for Conducting Vaccine Trials

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.

CLINICAL DEVELOPMENT

Site Management

Data Management

Site Selection

Regulatory Submissions

Clinical Monitoring

Protocol Development

CLINICAL TRIAL SERVICES

Beta Trials Platform

First-in-human studies

Medical Devices

Pilot and Pivotal Device Studies

Phases I – III

We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards

MAIN THERAPEUTIC AREAS

Diabetes/Metabolic Syndromes
Infectious Diseases
Cardiovascular
Neurology
Respiratory
Oncology

Opportunities for Conducting Vaccine Trials

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

We offer the quickest start-up times in each country.
Efficient Clinical Site Selection and Contracting.
Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

Proven record of delivering rescue studies, we consistently exceed industry performance standards.
Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
At Cohortias, we prioritize short lines of communication to ensure efficient collaboration.
Swift adaptation to changes in the trial landscape to keep your study on schedule.

Opportunities for Conducting Vaccine Trials

We provide our services with offices in:

Argentina,
Brazil,
Colombia &
Mexico.

Opportunities for Conducting Vaccine Trials

The Cohortias Team

Opportunities for Conducting Vaccine Trials

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Opportunities for Conducting Vaccine Trials

Network & Partnerships

CROs alliance of Mexico

Health System of Tec de Monterrey

The Science CRO of Europe